Data from the study showed that single single – dose oral vaccine well tolerated and immunogenic, which shows that the desired immune response has been achieved. Incidence of reactogenicity symptoms and side effects after vaccination were similar to placebo. Important immune response was dose dependent. Positive immune response or seroconversion were 65, 5 percent and 80 percent (44/55 low and high low and high dose.
Level) Oral Ty800 Vaccine meets primary endpoints in the Phase 2 studyAVANT Immunotherapeutics announced that the double-blind, placebo-controlled, multi-center Phase 2 study of its typhoid vaccine met all primary endpoints. The Phase 2 study was an out-patient, dose study in 183 healthy volunteers that evaluated two doses of the vaccine and then Ty800. Every issue for six months after vaccination The endpoints of the Phase 2 study were to determine the optimal dose of Ty800 for further development in the area of safety, reactogenicity and immunogenicity of the vaccine.Earlier this year, the modules cohesion of the European Union in the European Union, and there is is currently eight European Sensei schemes configure with the new module. A site is to the University Heart Center, University Hospital Hamburg – Eppendorf in Germany, where Professor Stephan Willem*, Director of the Clinical Electrophysiology and his team with a cohesive afar manipulation catheters during the course EP method. – performance of procedures other with confidence to move usage cohesive and we find it easy catheters within the 3D hearts room, said Professor Stephan Willems. We can also a large reduction of the time we use are screening, which is an advantage for the patient and Doctors For instance, in some cases we can use the method with a less than 10 min to complete fluoroscopy time.